LiveOne (Nasdaq: LVO) Accelerates Revenue Growth with Intuizi AI, Driving Tesla Subscriber Conversions GlobeNewswire November 03, 2025 Key Insights: Tesla ad-supported subscribers have grown to 1M+ over the last year 60% ARPU increase to over $5 31%+ increase in subscription engagement since launch 22%+ increase in Plus/Premium conversions since launch LOS ANGELES, Nov. 03, 2025 […]

Achieve Life Sciences Meets Key Milestones Advancing Cytisinicline NDA for Smoking Cessation GlobeNewswire November 03, 2025 120-Day Safety Update Submitted to FDA ORCA-OL Long-Term Safety Trial Successfully ConcludedDSMC Completes Final Review of Cytisinicline, Finds No Drug Safety Concerns SEATTLE and VANCOUVER, British Columbia, Nov. 03, 2025 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc. (Nasdaq: ACHV),

IRADIMED CORPORATION Reports Record Third Quarter 2025 Financial Results Announces Regular Quarterly Cash Dividend of $0.17 Per Share and Raises Full-Year Guidance GlobeNewswire November 03, 2025 Reports record revenue of $21.2 million for the third quarter of 2025, an increase of $2.9 million, or 16%, compared to the same period in 2024. Reports record GAAP

Alico Inc. partners with Florida Department of Transportation to construct wildlife underpass along State Road 82 GlobeNewswire November 03, 2025 FORT MYERS, Fla., Nov. 03, 2025 (GLOBE NEWSWIRE) — Alico Inc., (“Alico” or the “Company”) (Nasdaq: ALCO) a Southwest Florida-based agribusiness and land management company with over 125 years of experience, has announced a strategic

BTCS to Participate in Upcoming November Conferences GlobeNewswire November 03, 2025 WAYNE, Pa., Nov. 03, 2025 (GLOBE NEWSWIRE) — BTCS Inc. (Nasdaq: BTCS) (“BTCS” or the “Company”), a blockchain technology-focused company, short for Blockchain Technology Consensus Solutions, today announced that management will be participating in the following November 2025 investor conferences. Blockchain FuturistDates: November 5-6,

CytoDyn Secures $30 Million Commitment from Yorkville Advisors GlobeNewswire November 03, 2025 VANCOUVER, Washington, Nov. 03, 2025 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a clinical-stage oncology company advancing leronlimab, a first-in-class humanized monoclonal antibody targeting the CCR5 receptor with therapeutic potential across multiple indications, including triple-negative breast cancer (TNBC) and

Netramark Signs Contract with a Leading Global Biopharmaceutical Company to Enhance Clinical Trial Insights GlobeNewswire November 03, 2025 TORONTO, Nov. 03, 2025 (GLOBE NEWSWIRE) — NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company that is transforming clinical trials with AI powered precision analytics in

RESEARCH FRONTIERS TO HOST THIRD QUARTER 2025 CONFERENCE CALL GlobeNewswire November 03, 2025 WOODBURY, NY, Nov. 03, 2025 (GLOBE NEWSWIRE) — Research Frontiers Inc. (Nasdaq: REFR) announced today that it will release its third quarter 2025 financial results on Thursday, November 6, 2025. Research Frontiers will also host a conference call at 4:30 p.m. Eastern

Vatica Health has merged with Cozeva, expanding leadership in value-based care enablement GlobeNewswire November 03, 2025 ATLANTA, Nov. 03, 2025 (GLOBE NEWSWIRE) — Vatica Health (“Vatica”), a Frazier Healthcare portfolio company and leader in provider-centric, prospective risk adjustment and clinical quality solutions, is pleased to announce the closing of its merger with Cozeva, a premier

Amarin To Present New Analyses Affirming Robustness of Data from REDUCE-IT and Additional Mechanisms of Action of Eicosapentaenoic Acid (EPA) at American Heart Association (AHA) Scientific Sessions 2025 GlobeNewswire November 03, 2025 DUBLIN and BRIDGEWATER, N.J., Nov. 03, 2025 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ: AMRN), a company committed to advancing the science of